Journal of Headache and Pain

Aims & Scope

The Journal of Headache and Pain is a peer-reviewed open access journal published under the brand BMC, part of Springer Nature.

It is specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data.

With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine.

The journal publishes research articles, reviews, letters to the Editor as well as consensus articles and guidelines, which promote best practice in the management of patients with headaches and related pain.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 3,090.00 EUR. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019

  Citation: 658

  Authors: T. J., L. J., R., D., Z.

• The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates

  Citation: 549

  Authors: Lars Jacob, Knut, Mattias, Timothy J.

• Migraine is first cause of disability in under 50s: will health politicians now take notice?

  Citation: 466

  Authors: Timothy J., Lars J., Theo, R., Z.

• Prevalence of headache in Europe: a review for the Eurolight project

  Citation: 395

  Authors: Lars Jacob, Colette

• The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF)

  Citation: 320

  Authors: M., T. J., A. T., R. B.

• Migraine and psychiatric comorbidity: a review of clinical findings

  Citation: 310

  Authors: Fabio, Giuseppe, Federica, Gian Camillo, Paolo, Alfredo

• The impact of headache in Europe: principal results of the Eurolight project

  Citation: 291

  Authors: Timothy J, Lars Jacob, Zaza, Jose Miguel, Christian, Michel, Daiva, Elena, Cristina, Jessica, Colette

• European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

  Citation: 279

  Authors: Simona, Lars, Messoud, Uwe, Gisela, Dimos-Dimitrios, Paolo

• Gut-brain Axis and migraine headache: a comprehensive review

  Citation: 275

  Authors: Mahsa, Soodeh Razeghi, Zeinab, Fahimeh, Paolo, Amir, Simona, Mansoureh

• European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

  Citation: 272

  Authors: Simona, Faisal Mohammad, Messoud, Lars, Christina I., Raquel, Zaza, Antoinette, Paolo, Dimos-Dimitrios, Raffaele, Uwe, Margarita, Alexandra J., Gisela, Derya, Jan, Christian